eTheRNA
The company provides integrated RNA-LNP technology platforms and manufacturing solutions for pharmaceutical and biotechnology organizations. They specialize in proprietary LNP delivery systems, mRNA chemistry for sequence engineering, and cGMP-accredited production of RNA materials. Their services support the development of nucleic acid-based therapeutics from early discovery through clinical stages, targeting applications in oncology and autoimmune diseases.
Biotechnology
Pharmaceuticals
Life Sciences
Healthtech
Funding summary
- Total raised
- €73.0M
- Funding rounds
- 2
Investors in eTheRNA
Investors on record for eTheRNA. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like eTheRNA?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors